The Pentagon’s $1 Billion Buying Spree to Stockpile Critical Minerals
The U.S. Defense Department is moving to secure up to $1 billion in critical minerals, a strategic play to curb China’s dominance in materials essential for defense and technology manufacturing.
Why the AI Rally Might Be Too Hot to Handle
The latest surge in AI-linked stocks is dazzling investors but raising a the question: have markets learned anything from 1999?
Retail Crowding Drives Alpha, Institutions Are Watching
Individual investors are displaying remarkable alpha generation, pulling ahead of the broader market with conviction. However, this surge in trading is making institutional desks nervous that retail’s favorite stocks are becoming dangerously crowded and overvalued.
Investors Eye Gold and Silver, but Palladium’s Surge is Demanding Attention
Gold and silver may be dominating headlines with record highs, but palladium is quietly staging a comeback. Prices are up more than 34% this year, driven by industrial demand and tightening supply, positioning the metal as one to watch.
Trilogy Metals Shares Surge Over 200% After U.S. Takes 10% Stake
Trilogy Metals shares skyrocketed after the U.S. government announced a $35.6 million investment, signaling a renewed federal commitment to securing America’s critical mineral supply chains and advancing domestic resource development in Alaska.
Pharma Stocks Split as Trump Unveils 100% Drug Tariff
Trump’s 100% tariff on foreign-made branded drugs has shaken markets, with analysts warning the impact won’t be evenly felt.
Should You Invest in Gold? 7 Experts Weigh In
Gold futures have surged past $3,700 an ounce, prompting experts to weigh in on whether investors should jump in—or has that ship sailed?
Nvidia to Invest $100B in OpenAI, Cementing Partnership
Nvidia and OpenAI are joining forces in a landmark $100 billion partnership, combining Nvidia’s GPU leadership with OpenAI’s AI development to shape the next era of artificial intelligence.
This Biotech’s Phase 3 Results Could Be a Game-Changer for Investors
The next few weeks for aTyr Pharma will reveal a great deal about this company’s future. aTyr Pharma is set to transform treatment for pulmonary sarcoidosis and unlock blockbuster potential. Is the stock a good investment right now? Let’s find out.
Top Tip: Mining Multibagger, Ready to Run
U.S. junior critical mineral miner, ARES STRATEGIC MINING (CSE: ARS | FRA: N8I1 | OTC: ARSMF), is about to have its long-awaited Cinderella moment. For 5 years now, ARES has owned the only permitted fluorspar mine in the U.S. out of Delta, Utah. They’ve been drilling, fund-raising and constructing facilities, all the while hoping someone […]
German 
English